Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Castelfranco Veneto
Clinical trial register · Italy

Clinical Trials in Castelfranco Veneto, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6795 matching records held by the registry are in this view. Synced 14 Oct 2026, 03:19 UTC
6795
Studies in scope
all four open statuses
4083
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2849 Bologna 1304 Roma 1270 Naples 981 Rome 969
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fondazione Italiana Linfomi - ETS7 Gruppo Italiano Malattie EMatologiche dell'Adulto4 Merck Sharp & Dohme LLC2 AstraZeneca2 Janssen Research & Development, LLC1
Site location
Milan2849 Bologna1304 Roma1270 Naples981 Rome969
All 489 locations
Target enrolment
to

Trials with a site in Castelfranco Veneto

24 of 6795 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Fondazione Italiana Linfomi - ETS
Observational
1,000
Candiolo, Castelfranco Veneto, Alessandria, Aviano, Bari, Bergamo, Bologna, Brescia
2026-10
Not yet open
Fondazione EMN Italy Onlus
Observational
92
Bari, Bologna, Brescia, Castelfranco Veneto, Como, Milan, Novara, Pavia
2026-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Naples, Rome, Milan, Rozzano, Orbassano, Florence, Castelfranco Veneto, Peschiera del Garda
2025-11-26
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Bari, Genoa, Rome, Pisa, Castelfranco Veneto, Milan, Naples, Parma
2025-09-30
Recruiting
Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
NCT06588205Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Fondazione Italiana Linfomi - ETS
Observational
200
Alessandria, Ancona, Bari, Brescia, Candiolo, Castelfranco Veneto, Catania, Civitanova Marche
2025-05-05
Recruiting
AstraZeneca
Phase 2
80
Bologna, Castelfranco Veneto, Florence, Milan, Naples, Pavia, Pisa, Roma
2025-03-12
Recruiting
Fondazione Italiana Linfomi - ETS
Observational
130
Alessandria, Ancona, Avellino, Aviano, Brescia, Castelfranco Veneto, Florence, Milan
2024-04-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Cona, Meldola, Milan, Florence, Pisa, Castelfranco Veneto, Alessandria, Ancona
2023-12-31
Recruiting
The Lymphoma Academic Research Organisation
Phase 3
260
Bologna, Castelfranco Veneto, Cuneo, Latina, Lecce, Milan, Modena, Pavia
2023-09-05
Active, closed
AstraZeneca
Phase 3
142
Castelfranco Veneto, Foggia, Palermo, Pisa, Rozzano
2023-08-16
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Acquaviva delle Fonti, Asti, Avellino, Castelfranco Veneto, Milan, Naples, Ravenna, Rome
2023-03-23
Active, closed
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
NCT05024773Bladder Carcinoma in Situ (CIS)
Fidia Farmaceutici s.p.a.
Phase 3
130
Bergamo, Bologna, Castelfranco Veneto, Florence, Lecce, Milan, Naples, Roma
2022-12-29
Recruiting
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
NCT05524298Low Grade Non-Hodgkin's Lymphoma, Adult
Fondazione Italiana Linfomi - ETS
Observational
150
Alessandria, Ancona, Bari, Brescia, Castelfranco Veneto, Catania, Florence, Messina
2022-12-07
Active, closed
Eli Lilly and Company
Phase 3
925
Meldola, Rome, Milan, Castelfranco Veneto, Terni, Trento
2022-04-14
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
101
Alessandria, Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Castelfranco Veneto
2021-12-03
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 3
605
Meldola, Legnano, Sassuolo, Monza, Aviano, Pagani, Candiolo, Castelfranco Veneto
2021-12-01
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicable
72
Bologna, Bolzano, Castelfranco Veneto, San Giovanni Rotondo, Treviso
2021-06-09
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
274
Alessandria, Ancona, Ascoli Piceno, Bari, Bologna, Brescia, Brindisi, Castelfranco Veneto
2020-11-27
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
414
Alessandria, Ancona, Ascoli Piceno, Avellino, Bari, Bologna, Caserta, Castelfranco Veneto
2020-09-24
Active, closed
Screening for Abdominal Aortic Aneurysm and Popliteal Artery Aneurysm
NCT05360108Aortic Aneurysm, Abdominal, Popliteal Artery Aneurysm
Centre Hospitalier Universitaire Vaudois
Observational
507
Castelfranco Veneto, Padova, Roma, Rovigo
2020-06-01
Active, closed
Novo Nordisk A/S
Phase 3
134
Florence, Castelfranco Veneto, Milan, Udine, Verona
2019-10-21
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
75
Castelfranco Veneto, Alessandria, Ancona, Avellino, Aviano, Bari, Brescia, Cagliari
2019-07-02
Recruiting
Octapharma
Observational
200
Bari, Bologna, Castelfranco Veneto, Catania, Florence, Milan, Padova, Rome
2018-02-13
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 3
128
Milan, Ravenna, Candiolo, Castelfranco Veneto, Terni, Busto Arsizio, Alessandria, Ascoli Piceno
2014-05
Rows per page Showing 1–24 of 24
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 October 2026. https://priyalifescience.com/clinical-trials-italy/city/castelfranco-veneto

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,795 studies in total at the last sync on 14 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 24 of those studies with a site in Castelfranco Veneto.

How many clinical trials are recruiting in Castelfranco Veneto?

10 of the 24 studies on this page are recruiting new participants as of the 14 Oct 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 12 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Castelfranco Veneto), 24 studies
PhaseStudiesRecruitingShare
Phase 312450%
Observational7429.2%
Phase 23112.5%
Not applicable104.2%
Phase 2/3114.2%

Most active sponsors

Lead sponsors with the most studies (Castelfranco Veneto)
Lead sponsorStudiesRecruiting
Fondazione Italiana Linfomi - ETS73
Gruppo Italiano Malattie EMatologiche dell'Adulto42
AstraZeneca21
Merck Sharp & Dohme LLC21
Bristol-Myers Squibb11
Centre Hospitalier Universitaire Vaudois10
Eli Lilly and Company10
Fidia Farmaceutici s.p.a.10
Fondazione EMN Italy Onlus10
Janssen Research & Development, LLC10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.